(Q77220551)
Statements
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 (English)
M Lazzari
V Facchinetti
S Bernasconi
G Borleri
T Barbui